Thank you for your interest in this activity.
|
|
|
|
Pediatric Respiratory Disease: Defining the Risk and Reducing the Burden of Respiratory Syncytial Virus
|
|
Author(s)/Faculty: Michael L. Forbes, MD, FAAP; Gary Goodman, MD; John J. LaBella, MD
more
Michael L. Forbes, MD, FAAP; Gary Goodman, MD; John J. LaBella, MD
|
|
Source: Pediatric SuperSite
|
Type: Monograph
|
Number of Articles: 1
|
|
Release Date: May 2009
|
Expiration Date: May 31, 2010
|
Cost: $0.00 / $0.00
|
|
Credit Type: CME
|
Number of Credit(s): 1.00
|
Provider:
|
OVERVIEW
Respiratory syncytial vrus (RSV) infection is a signifi cant health burden, especially in premature infants. Despite this, prophylaxis coverage of high-risk infants and infants born prematurely is suboptimal. This monograph will review the pathophysiology and epidemiology of RSV
infection, focusing on this uniquely vulnerable population. Management methods and treatment options will be evaluated. The importance of prophylaxis will be presented, along with guidelines put forth by the American Academy of Pediatrics regarding treatment and prophylaxis for high risk, preterm, and late preterm infants. Practical advice for overcoming barriers to achieving adequate prophylaxis and adherence to treatment regimens will be given.
|